Quest Partners LLC Mirum Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 22,580 shares of MIRM stock, worth $1.17 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
22,580
Previous 1,829
1134.55%
Holding current value
$1.17 Million
Previous $75.6 Million
1245.03%
% of portfolio
0.11%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
228Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$352 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$247 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$168 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$145 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$132 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.9B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...